Updated CAP Protocols Explained

April 20, 2026
3 min

The Pathologist

Objective:

To outline the changes in cancer reporting protocols for head and neck cancers by the College of American Pathologists (CAP).

Approach:

Key Findings:

Introduction of specific protocols for HPV-associated oropharyngeal cancer, nasopharyngeal tumors, and others.
New section on tumor bed margin status and expanded lymph node reporting.
Mandatory reporting of previously optional data points for clinical decision-making.
Revised biomarker reporting criteria, including HER2 scoring and new antibodies.
Refinements in terminology and tumor descriptions to enhance clarity and consistency.

Interpretation:

The updates reflect a deeper understanding of head and neck cancers, particularly regarding HPV-related tumors, and aim to improve diagnostic accuracy and treatment planning.

Limitations:

The article does not provide specific examples of how the changes will be implemented in practice.
Potential challenges in training pathologists on the new protocols are not addressed.

Conclusion:

The updated CAP protocols signify a commitment to precise and clinically actionable reporting in head and neck cancer pathology, enhancing the integration of molecular and biomarker information.

Updated CAP Protocols Explained

Objective:

Approach:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Original Source(s)

Updated CAP Protocols Explained

Related Content

Rare GI disease leads to 20-plus units of transfused blood

What Will Analytical Science Look Like in 2036? Part One: The AI Age

Two General Sessions, One Reason to Be in Montréal